GEORGIA KELLY-WILLIAMS: Open Payments
NPI 1104545037 · DEER PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 22 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $474 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $182 |
| Lundbeck LLC | 7 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $113 |
| ABBVIE INC. | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $31 |
Products named: ABILIFY MAINTENA, CAPLYTA, REXULTI, VRAYLAR, COBENFY, FANAPT, Auvelity, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
